Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

• Main Authors: Adriana Bezerra-Souza (Author), Raquel Fernandez-Garcia (Author), Gabriela F. Rodrigues (Author), Francisco Bolas-Fernandez (Author), Marcia Dalastra Laurenti (Author), Luiz Felipe Passero (Author), Aikaterini Lalatsa (Author), Dolores R. Serrano (Author)
• Format: Book
• Published: MDPI AG, 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver and spleen, and can lead to death if not treated. Available treatments are not well tolerated due to...